India, Sept. 25 -- The following biotech and healthcare-related stocks were in focus on September 25, 2026, following developments including an initial public offering, diagnostic reimbursement expansion, regulatory fee waivers, value-based care expansion and portfolio investment changes.
ADARx Pharmaceuticals Inc. (ADRX)
ADARx Pharmaceuticals is a late-stage biotechnology company developing next-generation siRNA therapeutics.
The company priced its upsized initial public offering at $17.00 per share, offering 26.25 million shares and expecting approximately $446.3 million in gross proceeds.
ADARx also granted underwriters an option to purchase up to 3.94 million additional shares. AbbVie has agreed to invest up to $100 million in a con...